Sahajal Dhooria; Ritesh Agarwal Disclosures Future Microbiol. 2014;9 (10):1195-1208.

Recent GINA guidelines no longer recommend SABA alone and state AIR/MART is the preferred treatment for asthma over the age of 6 years. 3 Some respiratory specialists are building experience in the ...

On May 6, 2025, the Global Initiative For Asthma (GINA) published the 2025 update to their Global Strategy for Asthma ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric respiratory syncytial virus (RSV) infections in China. Addressing 12 clinical ...

Pediatric Asthma and Related Allergic and Nonallergic Diseases: Patient-Oriented Evidence-Based Essentials That Matter Miles Weinberger Disclosures Pediatr Health. 2008;2 (5):631-650. 0 ...

TUESDAY, June 17, 2025 (HealthDay News) — It is feasible to use electronic health record (EHR) data in the Pediatric Asthma Risk Score (PARS) to accurately predict childhood asthma risk, according to ...

The analysis included data from 69,109 children born between 2010 and 2017, of whom 5,290 (7.65 percent) had a confirmed asthma diagnosis after age 4 years.

For the study, researchers used the tool to comb through records of more than 69,000 Indiana children born between 2010 and 2017, of whom just under 8% had been diagnosed with asthma after age four.

The 2025 Global Initiative for Asthma (GINA) guidelines recommend against using short-acting β-agonist (SABA)-only reliever treatment for asthma in patients aged 12 years and older, due to the ...

The tool scans electronic health data records and calculates an asthma risk score for children, according to results published recently in eClinical Medicine. It relies on information that’s routinely ...